News

Article

ChargePoint Acquires Assets of Forac

ChargePoint Technology announced that it has acquired the assets of Forac Limited.

ChargePoint Technology, a UK-based manufacturer and supplier of precision containment valves to the pharmaceutical and chemical industries, announced that it has acquired the assets of Forac Limited, a key business in its supply chain.

Under the deal, ChargePoint will have access to a compact pneumatic actuator used to open and close the isolation valves that feature in production processes used by the pharmaceutical, food and fuel industries. No financial terms were disclosed.

Forac will relocate its plant and stock from a base in Shoreham-by-Sea, West Sussex to ChargePoint’s manufacturing plant in Speke, Merseyside. Founder and managing director of Forac Adam Bunyard has joined ChargePoint as part of the deal.

ChargePoint’s containment valves are used for the safe and sterile handling of powders in manufacturing processes, for example when making drugs in tablet form. The valves enable safe transferring of powders from one vessel to another during the production process. By minimizing dust emissions, they are specified to prevent cross-contamination and protect operators from exposure to potent substances.

Source: ChargePoint 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content